An electrocardiogram (ECG) is a non-invasive test used to check the heart's rhythm and electrical activity. ECG is often used alongside other tests to diagnose and monitor conditions affecting the heart. It is an integral part of the initial evaluation of a patient suspected of having a cardiac-related problem. Thus, there is an increasing demand for ECG monitors worldwide.
Market Dynamics:
Rise in burden of cardiovascular disease (CVDs), growing geriatric population, increasing demand for ECG for the diagnosis of cardiac diseases, and increasing adoption and demand for portable or technologically advanced ECG monitors are major factors expected to augment the growth of the global electrocardiograph market over the forecast period.
For instance, in April 2023, Icentia, a medical technology company, secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ambulatory, continuous electrocardiogram (ECG) monitoring solution, CardioSTAT. The wire-free and single-use CardioSTAT recorder is a flexible, lightweight, and showerproof device, which can be easily worn on the upper chest for the cardiac monitoring. CardioSTAT has the potential to provide up to 14 days of continuous ECG recording and analysis with a compliance rate of 99.9%.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook